Clinical Trial: LDH as a Biochemical Biomarker to Predict Organ Failure in the Emergency Department Setting

Study Status: Completed
Recruit Status: Completed
Study Type: Observational

Official Title: LDH as a Biochemical Biomarker to Predict Organ Failure in the Emergency Department Setting

Brief Summary: The purpose of this study is evaluate if K3, a novel biomarker, sampled at arrival to the emergency department can be used to predict the development of organ failure measured as SOFA score. K3 consists of lactate dehydrogenase, albumin and magnesium combined.

Detailed Summary:
Sponsor: Karolinska Institutet

Current Primary Outcome: Development of multiple organ failure [ Time Frame: 30 days or complete ICU stay ]

Measured as SOFA score.


Original Primary Outcome: Same as current

Current Secondary Outcome:

  • Cardiac function [ Time Frame: 30 days or complete ICU stay ]
    Is it possible to predict cardiac function with the novel biomarker K3, which consists of lactate dehydrogenase, albumin, and magnesium combined?
  • All cause mortality [ Time Frame: 30 days after admission to emergency department ]


Original Secondary Outcome: Same as current

Information By: Karolinska Institutet

Dates:
Date Received: August 30, 2013
Date Started: September 2013
Date Completion:
Last Updated: September 3, 2016
Last Verified: September 2016